Related references
Note: Only part of the references are listed.Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission
Kristy M. Bialas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Cytomegalovirus vaccine: phase II clinical trial results
F. Rieder et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus
Maria Grazia Revello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Neutralizing Anti-gH/gL Monoclonal Antibody Is Protective in the Guinea Pig Model of Congenital CMV Infection
Marcy R. Auerbach et al.
PLOS PATHOGENS (2014)
An Attenuated Cytomegalovirus Vaccine with a Deletion of a Viral Chemokine Gene Is Protective against Congenital CMV Transmission in a Guinea Pig Model
Michael P. Leviton et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Congenital Cytomegalovirus Infection: Clinical Outcome
Suresh B. Boppana et al.
CLINICAL INFECTIOUS DISEASES (2013)
Fetal Human Cytomegalovirus Transmission Correlates with Delayed Maternal Antibodies to gH/gL/pUL128-130-131 Complex during Primary Infection
Daniele Lilleri et al.
PLOS ONE (2013)
Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 Trial
Larry R. Smith et al.
VACCINES (2013)
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers
David I. Bernstein et al.
VACCINE (2009)
A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain)
Mark A. Jacobson et al.
VACCINE (2009)
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects
Mary K. Wloch et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus
Daniele Lilleri et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection
Mark R. Schleiss et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Passive immunization during pregnancy for congenital cytomegalovirus infection
G Nigro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Progress toward an elusive goal: current status of cytomegalovirus vaccines
Mark R. Schleiss et al.
EXPERT REVIEW OF VACCINES (2005)
Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein B antibody transfer in guinea pigs
A Chatterjee et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects
K Berencsi et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Share Paper
